BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
351 results:

  • 1. METTL3's role in cervical cancer development through m
    Liu Y; Li C; Deng Q; Ren X; Wang H
    FASEB J; 2024 Jun; 38(11):e23693. PubMed ID: 38809685
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Retraction Note: BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mtor in cervical cancer cells.
    Li FH; Xiang L; Ran L; Zhou S; Huang Z; Chen M; Yu WF
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3294. PubMed ID: 38766787
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mtor pathway and tubulin inhibition.
    Li SS; Chen JJ; Zhang MM; Wang WX; Zhang WY; Ma C
    Eur J Med Chem; 2024 May; 271():116425. PubMed ID: 38636129
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mtor pathway.
    Yin Q; Zhou Q; Hu J; Weng J; Liu S; Yin L; Long L; Tong Y; Tang K; Bai S; Ou L
    J Trace Elem Med Biol; 2024 Jul; 84():127437. PubMed ID: 38564977
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Khan NG; Adiga D; Rai PS; Kabekkodu SP
    Toxicology; 2024 May; 504():153791. PubMed ID: 38555994
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative analysis of chemical profiles, antioxidant, antibacterial, and anticancer effects of essential oils of two Thymus species from Montenegro.
    Preljević K; Pašić I; Vlaović M; Matić IZ; Krivokapić S; Petrović N; Stanojković T; Živković V; Perović S
    Fitoterapia; 2024 Apr; 174():105871. PubMed ID: 38428618
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antioxidant, Cytotoxic, Anti-Glycation, and Anti-Tyrosinase Compounds from the Leaves of Uvaria Siamensis.
    Wongwad E; Jadsadajerm S; Mungmai L; Wisetsai A
    Chem Biodivers; 2024 Apr; 21(4):e202400319. PubMed ID: 38423999
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.
    Coleman N; Stephen B; Fu S; Karp D; Subbiah V; Ahnert JR; Piha-Paul SA; Wright J; Fessahaye SN; Ouyang F; Yilmaz B; Meric-Bernstam F; Naing A
    Cancer Med; 2024 Feb; 13(3):e6877. PubMed ID: 38400671
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetics and beyond: Precision Medicine Real-World Data for Patients with cervical, Vaginal or Vulvar cancer in a Tertiary cancer Center.
    Kraus FBT; Sultova E; Heinrich K; Jung A; Westphalen CB; Tauber CV; Kumbrink J; Rudelius M; Klauschen F; Greif PA; König A; Chelariu-Raicu A; Czogalla B; Burges A; Mahner S; Wuerstlein R; Trillsch F
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397025
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
    Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Wang J; Mou X; Lu H; Jiang H; Xian Y; Wei X; Huang Z; Tang S; Cen H; Dong M; Liang Y; Shi G
    Front Endocrinol (Lausanne); 2023; 14():1302074. PubMed ID: 38327905
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anticancer Properties of Baicalin against Breast cancer and other Gynecological cancers: Therapeutic Opportunities based on Underlying Mechanisms.
    Pourhanifeh MH; Farrokhi-Kebria H; Mostanadi P; Farkhondeh T; Samarghandian S
    Curr Mol Pharmacol; 2024; 17():e18761429263063. PubMed ID: 38284731
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
    Le-Trung N; Kanaori K; Waku T; Dang TTP; Kamei K
    BMC Complement Med Ther; 2024 Jan; 24(1):59. PubMed ID: 38281034
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Zhou J; Li H; Wu B; Zhu L; Huang Q; Guo Z; He Q; Wang L; Peng X; Guo T
    Sci Rep; 2024 Jan; 14(1):1860. PubMed ID: 38253629
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase I Study of mtorC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mtor/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The effects of HPV oncoproteins on host communication networks: Therapeutic connotations.
    Skelin J; Luk HY; Butorac D; Boon SS; Tomaić V
    J Med Virol; 2023 Dec; 95(12):e29315. PubMed ID: 38115222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Maackiain suppresses the development of cervical cancer via AMPK priming autophagy.
    He J; Xiang L; Zhu T; Wang H; Huang Y; Li H; Miao C; Zhuang Y; Cao Y
    J Pharm Pharmacol; 2024 Jan; 76(1):23-33. PubMed ID: 37934902
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer.
    Cheng H; Long J; Su J; Chu J; Wang M; Li Q
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3179-3194. PubMed ID: 37906274
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.